0,957  0,002  Genotoxic
0,942  0,001  Antimutagenic
0,896  0,004  Chemoprotective
0,881  0,002  UGT1A9 substrate
0,876  0,004  Antihypercholesterolemic
0,849  0,004  Cytostatic
0,836  0,005  Mutagenic
0,834  0,007  Caspase 9 stimulant
0,834  0,007  Teratogen
0,827  0,002  UGT1A1 substrate
0,828  0,011  Transcription factor NF kappa B inhibitor
0,815  0,005  Chemopreventive
0,805  0,003  Antihypoxic
0,808  0,008  Embryotoxic
0,796  0,002  Amylase inhibitor
0,797  0,007  Cyclophilin D inhibitor
0,797  0,007  Antidiabetic
0,780  0,004  Cholesterol antagonist
0,781  0,007  Carcinogenic
0,766  0,010  TNF expression inhibitor
0,750  0,004  Antipyretic
0,742  0,007  Sensitization
0,740  0,006  Antibacterial
0,756  0,022  Antiinflammatory
0,751  0,023  Apoptosis agonist
0,727  0,002  Xanthine oxidase inhibitor
0,717  0,009  Respiratory analeptic
0,709  0,004  Monophenol monooxygenase inhibitor
0,706  0,006  Proliferative diseases treatment
0,703  0,008  Antithrombotic
0,697  0,005  Vasodilator, coronary
0,692  0,005  Hypoglycemic
0,691  0,006  Antioxidant
0,684  0,003  Melanin inhibitor
0,691  0,010  Radioprotector
0,687  0,007  NOS2 expression inhibitor
0,682  0,005  Cardioprotectant
0,675  0,005  Ulceration
0,672  0,002  Hexokinase inhibitor
0,675  0,005  DNA damaging
0,667  0,005  DNA synthesis inhibitor
0,668  0,007  NOS3 expression inhibitor
0,647  0,007  Antipruritic, allergic
0,655  0,016  CYP2C9 substrate
0,644  0,005  UDP-glucuronosyltransferase substrate
0,675  0,038  Alpha-glucosidase inhibitor
0,635  0,005  Angiogenesis stimulant
0,645  0,025  Antineoplastic (lung cancer)
0,623  0,004  Interleukin agonist
0,641  0,024  CYP3A4 substrate
0,626  0,009  Hepatic disorders treatment
0,617  0,008  Free radical scavenger
0,612  0,009  Caspase 3 stimulant
0,605  0,004  Alpha-N-acetylglucosaminidase inhibitor
0,610  0,011  Cytotoxic
0,601  0,005  Topoisomerase II inhibitor
0,613  0,022  Antileukemic
0,587  0,004  NOS3 expression enhancer
0,590  0,011  Apoptosis antagonist
0,581  0,005  Sulfotransferase substrate
0,573  0,004  Aldehyde dehydrogenase inhibitor
0,572  0,004  UGT2B4 substrate
0,583  0,015  Analeptic
0,577  0,009  UGT1A6 substrate
0,571  0,004  VCAM1 expression inhibitor
0,597  0,035  Antineoplastic (breast cancer)
0,565  0,008  Antineoplastic (osteosarcoma)
0,565  0,014  Histamine release inhibitor
0,555  0,004  Alkylator
0,565  0,018  CYP2C19 substrate
0,549  0,007  Antihypertriglyceridemic
0,566  0,027  Antineoplastic (colorectal cancer)
0,560  0,022  Immunostimulant
0,541  0,004  Mediator release inhibitor
0,545  0,014  Antiparasitic
0,524  0,004  Protein kinase stimulant
0,522  0,003  Antispirochetal
0,533  0,015  Antineoplastic (brain cancer)
0,526  0,014  Nitric oxide antagonist
0,514  0,006  Hepatoprotectant
0,536  0,029  Antineoplastic (colon cancer)
0,513  0,011  Antineoplastic (lymphoma)
0,509  0,010  ICAM1 expression inhibitor
0,499  0,004  Expectorant
0,500  0,006  Interferon gamma antagonist
0,519  0,028  Immunosuppressant
0,491  0,004  Cystathionine beta-synthase inhibitor
0,488  0,003  UDP-glucose 4-epimerase inhibitor
0,495  0,012  Vascular (periferal) disease treatment
0,509  0,026  Antineoplastic (ovarian cancer)
0,509  0,026  Vasodilator, peripheral
0,482  0,003  Antihemorrhagic
0,486  0,008  Cyclic AMP phosphodiesterase inhibitor
0,480  0,004  Aldose reductase substrate
0,496  0,021  AR expression inhibitor
0,497  0,022  Antifungal
0,481  0,010  Radiosensitizer
0,477  0,008  Skin whitener
0,492  0,023  Antineoplastic (cervical cancer)
0,475  0,007  Antihypotensive
0,472  0,004  Neurotrophic factor enhancer
0,471  0,004  Antifungal enhancer
0,472  0,010  Antineoplastic (sarcoma)
0,493  0,033  Prostate cancer treatment
0,469  0,010  Antineoplastic (small cell lung cancer)
0,463  0,004  AMP-activated protein kinase stimulant
0,467  0,013  Interleukin 2 agonist
0,468  0,018  Antineoplastic (glioblastoma multiforme)
0,472  0,023  Antineoplastic (glioma)
0,469  0,025  Antineoplastic (pancreatic cancer)
0,445  0,003  Triose-phosphate isomerase inhibitor
0,443  0,004  NADH dehydrogenase inhibitor
0,457  0,021  Antidiabetic (type 2)
0,475  0,041  5 Hydroxytryptamine release inhibitor
0,449  0,016  Antineoplastic (liver cancer)
0,438  0,006  Muscular dystrophy treatment
0,436  0,005  Topoisomerase I inhibitor
0,442  0,014  RNA-directed DNA polymerase inhibitor
0,454  0,030  Antineoplastic (melanoma)
0,432  0,010  Non-steroidal antiinflammatory agent
0,428  0,007  Antipruritic, non-allergic
0,422  0,004  Antineoplastic, alkylator
0,440  0,022  Hypoxia-inducible factor 1 alpha inhibitor
0,416  0,010  Antineoplastic (squamous cell carcinoma)
0,439  0,034  Immunomodulator
0,407  0,005  Topoisomerase II alpha inhibitor
0,405  0,003  DNA repair enzyme inhibitor
0,468  0,069  Antineoplastic (solid tumors)
0,399  0,003  Antiviral (Influenza B)
0,423  0,028  Antineoplastic (non-small cell lung cancer)
0,404  0,014  Antiviral (Herpes)
0,385  0,004  Cyclooxygenase 3 inhibitor
0,392  0,011  Antiviral (Influenza)
0,381  0,004  Selectin antagonist
0,385  0,009  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,424  0,048  Stroke treatment
0,392  0,017  Antihelmintic
0,390  0,017  Septic shock treatment
0,385  0,013  Platelet adhesion inhibitor
0,413  0,043  5 Hydroxytryptamine release stimulant
0,371  0,010  Hemostatic
0,360  0,011  Peptidyltransferase inhibitor
0,376  0,028  Myocardial infarction treatment
0,361  0,016  UGT2B7 substrate
0,376  0,031  Tumour necrosis factor alpha release inhibitor
0,372  0,028  Vasodilator
0,350  0,010  Antidote
0,340  0,004  Photosensitizer
0,348  0,013  Lipid peroxidase inhibitor
0,364  0,032  Antineoplastic (renal cancer)
0,338  0,010  Acute respiratory distress syndrome (ARDS) treatment
0,345  0,018  DNA methylase inhibitor
0,358  0,034  Antidiabetic symptomatic
0,339  0,017  Antineoplastic (carcinoma)
0,329  0,008  Antitussive
0,372  0,058  Bone diseases treatment
0,323  0,010  DNA intercalator
0,321  0,009  Antineoplastic antibiotic
0,351  0,041  Antineoplastic (multiple myeloma)
0,361  0,052  Antimycobacterial
0,353  0,049  Antiosteoporotic
0,317  0,015  UGT2B15 substrate
0,305  0,003  Antirickettsial
0,305  0,005  Choleretic
0,304  0,006  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,305  0,009  Psychosexual dysfunction treatment
0,329  0,034  Antineoplastic (lymphocytic leukemia)
0,300  0,010  Cell wall synthesis inhibitor
0,329  0,045  Antineoplastic (endocrine cancer)
0,328  0,044  Antiamyloidogenic
0,303  0,025  DNA methyltransferase I inhibitor
0,291  0,018  Antiviral (Influenza A)
0,279  0,007  Beta glucuronidase inhibitor
0,278  0,008  Antibiotic
0,274  0,006  Phosphofructokinase-1 inhibitor
0,276  0,009  ATPase inhibitor
0,274  0,008  Mannose-6-phosphate isomerase inhibitor
0,273  0,007  Carbonic anhydrase XIII inhibitor
0,325  0,060  Lipoprotein disorders treatment
0,271  0,009  UGT2B1 substrate
0,271  0,014  Carcinogenic, group 1
0,277  0,021  Diabetic nephropathy treatment
0,259  0,005  Carcinogenic, group 2A
0,365  0,111  Antiarthritic
0,297  0,046  Amyloid beta aggregation inhibitor
0,268  0,017  Adenylate cyclase inhibitor
0,268  0,017  Antidiarrheal
0,262  0,013  Gout treatment
0,274  0,026  Antiviral (Hepatitis)
0,270  0,026  Antiacne
0,308  0,067  Spasmolytic
0,264  0,026  Carcinogenic, group 3
0,238  0,008  Mucolytic
0,259  0,029  Insulin sensitizer
0,249  0,020  Insulin secretagoues
0,238  0,010  Carbonic anhydrase III inhibitor
0,268  0,043  Wound healing agent
0,243  0,018  DNA polymerase I inhibitor
0,283  0,062  Transcription factor STAT3 inhibitor
0,227  0,010  Alcohol dehydrogenase inhibitor
0,244  0,028  Liver fibrosis treatment
0,310  0,096  Antineoplastic (non-Hodgkin's lymphoma)
0,253  0,043  Antialcoholic
0,234  0,024  Antidiabetic (type 1)
0,219  0,011  Carbonic anhydrase VI inhibitor
0,254  0,048  Anesthetic general
0,223  0,019  Cell adhesion inhibitor
0,241  0,039  Nitric-oxide synthase stimulant
0,273  0,072  Transcription factor STAT inhibitor
0,236  0,037  Thrombolytic
0,230  0,031  Cystic fibrosis treatment
0,286  0,089  CYP2D6 substrate
0,200  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,230  0,034  Hair growth stimulant
0,199  0,006  Heat shock protein 70 antagonist
0,196  0,004  Antibiotic Glycopeptide-like
0,204  0,013  Uric acid excretion stimulant
0,209  0,017  Antifungal (Cryptococcus)
0,229  0,037  UGT1A3 substrate
0,210  0,020  Interleukin 4 antagonist
0,235  0,047  P-glycoprotein inhibitor
0,188  0,003  Mannosidase inhibitor
0,225  0,040  Antihelmintic (Nematodes)
0,218  0,034  Antiviral (Ebola)
0,222  0,039  Antineoplastic (gastric cancer)
0,184  0,002  Heparanase inhibitor
0,191  0,010  Transcription factor NF kappa B stimulant
0,228  0,047  UGT1A4 substrate
0,271  0,091  CTGF expression inhibitor
0,184  0,005  Ca2+-transporting ATPase inhibitor
0,270  0,092  Antiischemic
0,218  0,040  Protein-tyrosine phosphatase inhibitor
0,185  0,009  Toll-Like receptor 4 antagonist
0,248  0,074  Antiprotozoal (Leishmania)
0,177  0,004  Topoisomerase II beta inhibitor
0,195  0,023  Carcinogenic, group 2B
0,178  0,006  Phosphorylase inhibitor
0,195  0,027  Glutathione S-transferase substrate
0,171  0,003  Antimycoplasmal
0,177  0,011  Antiviral (Trachoma)
0,204  0,039  Antiviral (Hepatitis C)
0,176  0,011  Thioredoxin inhibitor
0,260  0,097  Metabolic disease treatment
0,172  0,011  Keratolytic
0,179  0,019  Vanilloid 1 agonist
0,165  0,007  Phosphodiesterase 6D inhibitor
0,172  0,017  Chronic obstructive bronchitis treatment
0,179  0,026  Microtubule formation inhibitor
0,185  0,032  CF transmembrane conductance regulator agonist
0,198  0,046  Prostate disorders treatment
0,154  0,004  Alpha-mannosidase inhibitor
0,161  0,011  Postmenopausal disorders treatment
0,194  0,044  Interleukin 6 antagonist
0,227  0,079  Hypolipemic
0,238  0,091  Antineoplastic (bladder cancer)
0,148  0,002  Sodium/glucose cotransporter inhibitor
0,238  0,093  Gastrin inhibitor
0,193  0,049  Phospholipase C inhibitor
0,240  0,097  Antituberculosic
0,219  0,076  Antiulcerative
0,157  0,015  Antifungal (Pneumocystis)
0,151  0,011  Antiprotozoal activity enhancer
0,242  0,105  CYP1A2 substrate
0,212  0,075  Antineoplastic enhancer
0,172  0,036  Antiviral (Hepatitis B)
0,188  0,051  Antineoplastic (bone cancer)
0,173  0,038  Toll-Like receptor 2 antagonist
0,185  0,052  Neuropathy treatment
0,142  0,009  Antiviral (Dengue virus)
0,170  0,038  Protein-tyrosine phosphatase 1B inhibitor
0,133  0,002  Sodium/glucose cotransporter 1 inhibitor
0,164  0,032  Growth stimulant
0,132  0,002  Sodium/glucose cotransporter 2 inhibitor
0,150  0,020  Actinic keratosis treatment
0,143  0,014  HIV-1 integrase (3'-Processing) inhibitor
0,137  0,010  GABA aminotransferase inhibitor
0,214  0,092  Platelet antagonist
0,132  0,012  Glycine receptor antagonist
0,130  0,011  Na+ K+ transporting ATPase inhibitor
0,268  0,149  Antineoplastic (myeloid leukemia)
0,172  0,053  Contraceptive
0,163  0,044  Adenylate cyclase stimulant
0,132  0,015  HIV-1 integrase (Strand Transfer) inhibitor
0,174  0,059  Acaricide
0,175  0,061  UGT2B10 substrate
0,204  0,089  Antiviral (HIV)
0,125  0,013  Estrogen agonist
0,144  0,033  Anticataract
0,121  0,011  Neuraminidase (influenza) inhibitor
0,125  0,016  ATPase (Vacuolar H+) inhibitor
0,126  0,018  Glutamate release inhibitor
0,145  0,039  Antineoplastic (uterine cancer)
0,153  0,047  Antihyperlipoproteinemic
0,131  0,025  NAD(P)H dehydrogenase (quinone) inhibitor
0,109  0,003  Cholesterol absorption inhibitor
0,225  0,121  Antipsoriatic
0,141  0,038  TRPA1 agonist
0,156  0,055  Renal failure treatment
0,110  0,011  Protein 50S ribosomal subunit inhibitor
0,132  0,034  Dementia treatment
0,098  0,001  Vanilloid 2 agonist
0,115  0,020  Histone deacetylase stimulant
0,115  0,020  Histone deacetylase SIRT1 stimulant
0,132  0,036  Estrogen antagonist
0,128  0,034  Vascular dementia treatment
0,119  0,025  Interleukin 5 antagonist
0,096  0,003  Protein 30S ribosomal subunit inhibitor
0,113  0,020  Interferon agonist
0,145  0,054  Retinoprotector
0,141  0,050  Cholesterol synthesis inhibitor
0,118  0,027  Ornithine decarboxylase inhibitor
0,100  0,011  Carbonic anhydrase XIV inhibitor
0,107  0,019  Narcotic antagonist
0,271  0,184  Calcium channel L-type activator
0,101  0,015  Neuraminidase inhibitor
0,092  0,006  Glucose-6-phosphate isomerase inhibitor
0,089  0,004  Antibiotic Aminoglycoside-like
0,151  0,066  Antiprotozoal (Coccidial)
0,086  0,007  Adenine nucleotide translocase inhibitor
0,096  0,017  Xanthine dehydrogenase inhibitor
0,223  0,145  Angiogenesis inhibitor
0,097  0,019  Aldose reductase inhibitor
0,105  0,028  Glutamate dehydrogenase inhibitor
0,123  0,048  HDL-cholesterol increasing
0,112  0,037  Interleukin 12 antagonist
0,148  0,079  UGT2B9 substrate
0,225  0,156  Sodium/bile acid cotransporter inhibitor
0,167  0,098  Sepsis treatment
0,087  0,019  Interferon inducer
0,148  0,080  Eye irritation, high
0,160  0,092  Lipocortins synthesis antagonist
0,091  0,024  Antitreponemal
0,097  0,031  Thioredoxin reductase inhibitor
0,095  0,031  CDC25A inhibitor
0,083  0,019  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,085  0,024  CDC25B inhibitor
0,067  0,006  Guanylate cyclase inhibitor
0,108  0,048  UGT2B11 substrate
0,130  0,070  CC chemokine 6 receptor antagonist
0,079  0,019  Fatty acid synthase inhibitor
0,155  0,096  Diabetic retinopathy treatment
0,102  0,043  Arylamine N-Acetyltransferase substrate
0,109  0,051  Anabolic
0,073  0,014  Glucose-6-phosphate translocase inhibitor
0,132  0,074  Alkaline phosphatase inhibitor
0,122  0,066  Contraceptive female
0,114  0,060  Chelator
0,101  0,047  SULT1E1 substrate
0,109  0,055  Adenylate kinase inhibitor
0,078  0,024  Nitric oxide donor
0,065  0,013  Factor III inhibitor
0,126  0,074  Antihelmintic (Trematoda)
0,088  0,041  T cell inhibitor
0,159  0,112  Abortion inducer
0,075  0,028  Antihemophilic
0,129  0,082  Neurotrophic factor
0,078  0,034  Anticholelithogenic
0,056  0,012  Arginase inhibitor
0,101  0,058  Antischistosomal
0,065  0,023  Leukotriene B4 antagonist
0,143  0,102  Dual specificity phosphatase inhibitor
0,056  0,016  Neuraminidase (Influenza A) inhibitor
0,059  0,020  Equilibrative nucleoside transport protein inhibitor
0,154  0,117  Antimitotic
0,046  0,009  Uridine phosphorylase inhibitor
0,113  0,078  Alcohol dehydrogenase substrate
0,078  0,044  Phosphodiesterase VI inhibitor
0,035  0,003  Antibiotic Anthracycline-like
0,062  0,031  Lipocortins synthesis agonist
0,068  0,038  DNA gyrase inhibitor
0,102  0,074  Endometrios treatment
0,193  0,165  5 Hydroxytryptamine uptake stimulant
0,080  0,052  Cell adhesion molecule inhibitor
0,106  0,078  Aldehyde dehydrogenase substrate
0,030  0,003  Telomerase stimulant
0,064  0,038  Purinergic P2X1 antagonist
0,033  0,007  GRP78 expression inhibitor
0,067  0,041  Hypercalcemia treatment
0,063  0,039  Prostaglandin EP2 antagonist
0,139  0,116  Sedative
0,039  0,016  Purinergic P2Y2 antagonist
0,051  0,029  Adenosine deaminase inhibitor
0,031  0,010  Toll-Like receptor 4 agonist
0,088  0,070  Antiviral (Rhinovirus)
0,035  0,018  Protein kinase C beta I inhibitor
0,120  0,104  Diuretic
0,035  0,018  Nucleoside transporters inhibitor
0,055  0,038  Protein kinase C eta inhibitor
0,152  0,137  Aldehyde oxidase inhibitor
0,088  0,074  Sphingomyelinase inhibitor
0,019  0,005  Antibiotic Tetracycline-like
0,034  0,022  Estrogen receptor beta agonist
0,101  0,090  Neutropenia treatment
0,085  0,074  Restless leg syndrome treatment
0,029  0,018  1,3-Beta-glucan synthase inhibitor
0,045  0,035  Microtubule stabilization
0,082  0,072  Aminoacyl-tRNA synthetase inhibitor
0,043  0,037  Carbonic anhydrase VII inhibitor
0,024  0,017  Adenosine A1 receptor agonist
0,127  0,121  Uterine stimulant
0,047  0,042  Factor IXa inhibitor
0,212  0,207  Antiprotozoal
0,040  0,036  DNA gyrase subunit A inhibitor
0,016  0,013  Ileal bile acid transport inhibitor
0,036  0,033  Retinoic acid alpha receptor agonist
0,021  0,019  Dopamine D1 agonist
0,054  0,051  Antidote, heavy metal
0,093  0,091  SULT1A1 substrate
0,088  0,086  Estrogen receptor beta antagonist

